Using a closure analysis method to reduce CGT contamination risks
Many cell therapy manufacturing processes use open unit manipulations. As a result, they are at risk of potential contam...
Supporting particle investigations with risk-based decision-making
BioPhorum’s Visual Inspection workstream has invested considerable time and effort to add clarity to the uncertainty around how to assess the risk of atypical particles during investigations. The team’s Standardized ...
Ask BioPhorum – a second brain for BioPhorum members
Whilst the filling and finish process is straightforward to describe, it is exquisitely complicated to get right and be ...
BioPhorum’s Deliverables Report 2021 – all of our content at your fingertips
Where can you read about industry trends, progress against shared challenges, and best practice solutions...
Bringing the needs of biopharmaceutical manufacturers and their suppliers closer
As a supplier, it can be hard to predict trends and anticipate the future needs of pharmaceutical manufacturers. With po...
Celebrating achievements and preparing for the long term
LONG READPreparing the industry to tackle risk assessment around PUPSITAs the BioPhorum and Parenteral Drug...
Meeting the challenges in serialization to win in the battle against counterfeiting
The World Health Organization (WHO) estimates that medicine counterfeiting causes one million deaths a year and that 10%...
Connecting vision systems with how the patient reads a label
The packaging of pharmaceutical products is regulated in most countries. Authorities expect that any printed information...
BioPhorum launch new sustainability phorum
BioPhorum members have given us a clear message; to be an industry that supports sustainability is extremely important t...
Chain reaction: how the biopharmaceutical supply chain survived the pandemic
LONG READChain reaction: how the biopharmaceutical supply chain survived the pandemicThe pressure on the...
Overcoming unique challenges to support rapid development of diverse products
LONG READOvercoming unique challenges to support rapid development of diverse productsThe Cell and Gene Therapy (CGT)...
How to perform aseptic process simulation for lyophilized products
Proposed 2020 revisions to EU Annex 1 around aseptic process simulation (APS) for lyophilized products have prompted ext...
The Power of Industry Collaboration: Driving Harmonization of Regulatory Requirements
Driving the harmonization of regulatory requirements – one country at a time Regulations play a significant role...
Sample sizing approaches
How do you justify your sample sizes for container closure integrity testing? Most leading biopharmaceutical compa...
Supporting particle investigations with risk-based decision-making
BioPhorum’s Visual Inspection workstream has invested considerable time and effort to add clarity to the uncertainty a...
Ask BioPhorum – a second brain for BioPhorum members
Whilst the filling and finish process is straightforward to describe, it is exquisitely complicated to get right and be ...
BioPhorum’s Deliverables Report 2021 – all of our content at your fingertips
Where can you read about industry trends, progress against shared challenges, and best practice solutions...
Bringing the needs of biopharmaceutical manufacturers and their suppliers closer
As a supplier, it can be hard to predict trends and anticipate the future needs of pharmaceutical manufacturers. With po...
Celebrating achievements and preparing for the long term
LONG READPreparing the industry to tackle risk assessment around PUPSITAs the BioPhorum and Parenteral Drug...
Meeting the challenges in serialization to win in the battle against counterfeiting
The World Health Organization (WHO) estimates that medicine counterfeiting causes one million deaths a year and that 10%...
Connecting vision systems with how the patient reads a label
The packaging of pharmaceutical products is regulated in most countries. Authorities expect that any printed information...
BioPhorum launch new sustainability phorum
BioPhorum members have given us a clear message; to be an industry that supports sustainability is extremely important t...
Chain reaction: how the biopharmaceutical supply chain survived the pandemic
LONG READChain reaction: how the biopharmaceutical supply chain survived the pandemicThe pressure on the...
Overcoming unique challenges to support rapid development of diverse products
LONG READOvercoming unique challenges to support rapid development of diverse productsThe Cell and Gene Therapy (CGT)...
How to perform aseptic process simulation for lyophilized products
Proposed 2020 revisions to EU Annex 1 around aseptic process simulation (APS) for lyophilized products have prompted ext...
The Power of Industry Collaboration: Driving Harmonization of Regulatory Requirements
Driving the harmonization of regulatory requirements – one country at a time Regulations play a significant role...